{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?creator.label=Biography+information+for+The+Countess+of+Mar&version=1", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?creator.label=Biography+information+for+The+Countess+of+Mar&version=1", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_metadata=all&creator.label=Biography+information+for+The+Countess+of+Mar&version=1", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&creator.label=Biography+information+for+The+Countess+of+Mar&version=1", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?creator.label=Biography+information+for+The+Countess+of+Mar&version=1", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?creator.label=Biography+information+for+The+Countess+of+Mar&version=1", "items" : [{"_about" : "http://data.parliament.uk/resources/1140485", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1140485/answer", "answerText" : {"_value" : "<p>The department is committed to ensuring claimants receive high quality assessments. We set our assessment providers challenging targets and monitor performance closely against a range of measures including through independent audit to improve accuracy and decision making. Contractual remedies are in place if assessment providers fail to deliver against the service standards.<\/p><p>Contractual remedies for underperformance against a range of service levels are recovered through service credit mechanisms and through deductions of payments (a \u2018No Pay\u2019 mechanism). The extent of underperformance and application of related mechanisms varies significantly and the regularity of such remedies should not be seen as a measure of overall performance.<\/p><p>In relation to the HDAS contract covering Work Capability Assessments, service credits (the contractual remedy for SC1 \u2013 Quality) have been applied in 12 out of the 14 months from June 2018 to July 2019 (the date of the most recent statistical information available).<\/p><p>In relation to the Personal Independence Payment contracts, \u201cNo Pay\u201d (the contractual remedy for SC1 \u2013 Quality) has been applied in one or more Lots in each month from June 18 to June 19 (the date of the most recent statistical information available).<\/p><p>Below is the breakdown of the totals by Lot:<\/p><p>Lot 1 \u2013 No pay was applied to SC1 in 8 of those months<\/p><p>Lot 2 \u2013 No pay was applied to SC1 in 5 of those months<\/p><p>Lot 3 \u2013 No pay was applied to SC1 in 11 of those months.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4174", "label" : {"_value" : "Biography information for Baroness Stedman-Scott"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Stedman-Scott"}
        , "dateOfAnswer" : {"_value" : "2019-08-12", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-08-12T15:58:29.597Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "29"}
      , "answeringDeptShortName" : {"_value" : "Work and Pensions"}
      , "answeringDeptSortName" : {"_value" : "Work and Pensions"}
      , "date" : {"_value" : "2019-07-18", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Social Security Benefits: Medical Examinations"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what controls and penalties are in place to ensure that providers of medical assessors for social security benefits maintain high standards of accuracy and integrity; and on how many occasions any such controls or penalties have been used since June 2018.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL17318"}
    , {"_about" : "http://data.parliament.uk/resources/1139574", "AnsweringBody" : [{"_value" : "Ministry of Defence"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1139574/answer", "answerText" : {"_value" : "<p>Anti-malarial drugs are prescribed to Service personnel with the UK product information leaflet. For mefloquine, this reflects the recommendations of the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency.<\/p><p>All anti-malarial drugs have contraindications and a side effect profile which can be found in the British National Formulary or online at the Electronic Medicines Compendium. It is Ministry of Defence policy that healthcare professionals undertake a health risk assessment and to warn patients of the possible side effects of any anti-malarial drug.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"}
        }
        , "answeringMemberPrinted" : {"_value" : "Earl Howe"}
        , "dateOfAnswer" : {"_value" : "2019-07-22", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-22T16:22:24.543Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "11"}
      , "answeringDeptShortName" : {"_value" : "Defence"}
      , "answeringDeptSortName" : {"_value" : "Defence"}
      , "date" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Armed Forces: Mefloquine"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 10 July (HL16834), what steps the Ministry of Defence has taken to address the concerns of the European Medicines Agency Pharmacovigilance Assessment Committee 2014 report on the toxicity of mefloquine (Lariam); and if they have not taken any such steps, why not.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL17221"}
    , {"_about" : "http://data.parliament.uk/resources/1135740", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1135740/answer", "answerText" : {"_value" : "<p>A meeting was held by the Global Advisory Committee on Vaccine Safety (GACVS) on 5 to 6 June 2019. However, the Medicines and Healthcare products Regulatory Agency is not aware of any formal review of human papillomavirus vaccine safety published by GACVS in 2019.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T10:24:58.8Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government whether they will place a copy of the World Health Organisation Global Advisory Committee on Vaccine Safety 2019 review of HPV vaccine safety in the Library of the House.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL16833"}
    , {"_about" : "http://data.parliament.uk/resources/1135741", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1135741/answer", "answerText" : {"_value" : "<p>At its meeting in February 2014, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recommended that the product information for mefloquine (Lariam) be amended to state that neuropsychiatric adverse reactions may persist for months, or longer, even after discontinuation of the drug. The Medicines and Healthcare products Regulatory Agency (MHRA) accepted the recommendations and implemented the advice of the PRAC, which is reflected in the United Kingdom product information for mefloquine. In addition, the MHRA has since taken further action to ensure that these risks are adequately conveyed to UK prescribers and patients in the form of improved checklists for healthcare professionals and a patient alert card.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-10T15:26:45.817Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Mefloquine"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the European Medicines Agency Pharmacovigilance Risk Assessment Committee\u2019s 2014 report on the toxicity of mefloquine (Larium).", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL16834"}
    , {"_about" : "http://data.parliament.uk/resources/1135742", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1135742/answer", "answerText" : {"_value" : "<p>Tris (1-chloro-2-propyl) phosphate (TCIPP) is also known by its regulatory process name, tris (2-chloro-1-methylethyl) phosphate (TCCP).<\/p><p> <\/p><p>The Environment Agency worked with chemical authorities in the Republic of Ireland to initially assess the risks of TCPP in 2008. The potential environmental and human health risks of TCPP in products and other objects are currently being considered by the European Chemicals Agency (ECHA) and European Union member state scientists. Subsequently, building on a greater body of evidence, the ECHA, supported by Danish and German work are evaluating the properties of this substance and considering a legal restriction on it.<\/p><p> <\/p><p>Further information on this is expected soon and will help identify the chemical properties and environmental risks from TCPP in products like furniture.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4161", "label" : {"_value" : "Biography information for Lord Gardiner of Kimble"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Gardiner of Kimble"}
        , "dateOfAnswer" : {"_value" : "2019-07-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-10T15:30:43.677Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "13"}
      , "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"}
      , "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"}
      , "date" : {"_value" : "2019-07-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Furniture: Fire Resistant Materials"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government whether they have assessed the environmental risks of disposing of polyurethane used in furniture which has been treated with tris (1-chloro-2-propyl) phosphate (TCIPP).", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL16835"}
    , {"_about" : "http://data.parliament.uk/resources/1135743", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1135743/answer", "answerText" : {"_value" : "<p>The Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment has considered the evidence on the potential effects of chlorinated and non-chlorinated phosphate flame retardants from all exposure sources, in general. The Committee is preparing a statement on phosphate-based flame retardants and the potential for neurodevelopmental toxicity. It is expected that the statement will be published in summer 2019.<\/p><p>Chlorinated organophosphorous flame retardants are regulated under the European Union REACH (Restriction, Evaluation, Authorisation and Restriction of Chemicals) regime. The United Kingdom has been proactive in supporting the regulation of flame retardants through REACH. The European Chemicals Agency has announced an intention to restrict a number of chlorinated flame retardants. It is expected that the restriction proposal will be submitted in July 2019, followed by a public consultation.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T10:24:38.953Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-01", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Mattresses: Fire Resistant Materials"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the risks to the neurological development of (1) foetuses, and (2) new-born children, of exposure to polyurethane mattresses treated with chlorinated phosphate flame retardants.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL16836"}
    , {"_about" : "http://data.parliament.uk/resources/1131897", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1131897/answer", "answerText" : {"_value" : "<p>The appointment is subject to the approval process which governs the Civil Service Commission Recruitment Principles. An announcement will be made once that process has concluded.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-06-26", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-06-26T12:11:36.557Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-06-12", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Food Standards Agency: Public Appointments"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government when they intend to approve the appointment of a Chief Executive for the Food Standards Agency; and what has been the cause of the delay.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL16315"}
    , {"_about" : "http://data.parliament.uk/resources/1131899", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1131899/answer", "answerText" : {"_value" : "<p>DecaBDE refers to Decabromodiphenyl Ether, a substance which falls under a wider group of chemicals known as Polybrominated Diphenyl Ethers (PBDEs). DecaBDE has not been produced in the UK since the late 1990s. DecaPBDE is not a term that is generally used to describe this or any other substance and no such substance is produced in the UK.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4161", "label" : {"_value" : "Biography information for Lord Gardiner of Kimble"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Gardiner of Kimble"}
        , "dateOfAnswer" : {"_value" : "2019-06-24", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-06-24T14:49:09.723Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "13"}
      , "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"}
      , "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"}
      , "date" : {"_value" : "2019-06-12", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Chemicals: Regulation"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government, further to the Written Answer by Lord Gardiner of Kimble on 4 June (HL15892), why, if the terms DecaBDE and DecaPBDE are interchangeable, DecaBDE has been banned whilst production of DecaPBDE continues.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL16317"}
    , {"_about" : "http://data.parliament.uk/resources/1128074", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1128074/answer", "answerText" : {"_value" : "<p>The Government has been reviewing the Furniture and Furnishings (Fire) (Safety) Regulations 1988. The 2016 consultation on updating the Furniture and Furnishings (Fire) (Safety) Regulations sought views on proposals for clarifying and amending the scope of the regulations. The Department will publish its response to the 2016 consultation in due course.<\/p><p> <\/p><p>Chemicals, including brominated and organophosphate flame retardants used in UK furniture, are regulated under Regulation (EC) No 1907/2006 on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). REACH aims to provide a high level of protection for health and the environment from the use of chemicals including those used in products.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2616", "label" : {"_value" : "Biography information for Lord Henley"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Henley"}
        , "dateOfAnswer" : {"_value" : "2019-06-05", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-06-05T16:20:19.737Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2019-05-22", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Mattresses: Fire Resistant Materials"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what was (1) the basis, and (2) the supporting evidence, for the proposal contained in the Department for Business, Energy and Industrial Strategy\u2019s 2016 consultation on the Furniture and Furnishings (Fire) (Safety) Regulations to continue to include children\u2019s mattresses in the scope of the Furniture and Furnishings (Fire) (Safety) Regulations 1988, in the light of the EU ban on the use of brominated and organophosphate chemicals in children\u2019s mattresses.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL15923"}
    , {"_about" : "http://data.parliament.uk/resources/1128075", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1128075/answer", "answerText" : {"_value" : "<p>The Furniture and Furnishings (Fire) (Safety) Regulations 1988 apply to upholstered furniture which is ordinarily intended for private use in a dwelling.<\/p><p> <\/p><p>The Regulatory Reform (Fire Safety) Order 2005 (FSO) is primarily for businesses and other non-domestic premises including communal areas of multi-occupied residential premises \u2013 where the communal areas are effectively workplaces and not primarily domestic premises. For care homes where the main use is the provision of residential care, the FSO applies to the entire premises as they are a workplace. It does not apply to people\u2019s private homes.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2616", "label" : {"_value" : "Biography information for Lord Henley"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Henley"}
        , "dateOfAnswer" : {"_value" : "2019-06-05", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-06-05T16:20:45.51Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2019-05-22", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Furniture: Fire Resistant Materials"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government, further to the Written Answer by Lord Henley on 21 May (HL15638), what steps they are taking to clarify which of the Furniture and Furnishings (Fire) (Safety) Regulations 1988 or the Regulatory Reform (Fire Safety) Order 2005 should take precedence in circumstances where either might apply, such as in (1) domestic and communal spaces in care homes, or (2) an office room based in a domestic dwelling.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL15924"}
    ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&creator.label=Biography+information+for+The+Countess+of+Mar&version=1", "page" : 0, "startIndex" : 1, "totalResults" : 211, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}